German drug maker Merck KGaA Tuesday announced 55.1 percent plunge in fourth quarter net profit owing to one time expenses in connection with takeover of U.S. based laboratory equipment maker Sigma-Aldrich. Meanwhile, net sales climbed 15.5 percent from the prior year. The board proposed an increase in dividend for the full year.